Pricing Log in Create free account
Saturday 17 October 2026 Export DGX’s income statement to Excel — free account

Quest Diagnostics Incorporated

DGX Healthcare Diagnostics & Research

Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 14.7%, free cash flow grew 5.28% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

235.00 4.15 −1.74%
Market cap
$26.4B
P/E
24.6×
Fwd P/E
20.8×
Dividend yield
1.44%
F-score
8/9
Altman Z
3.15
Beneish M
−2.65
Dividend safety
85/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Quest Diagnostics Incorporated (DGX) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Quest Diagnostics Incorporated (DGX) trades at a EV/Sales of 2.7×. Over the past ten years it has ranged from 1.6× (September 2015) to 2.8× (September 2026); the current reading is higher than 98% of that period. That is below the Diagnostics & Research industry median of 5.5× and below the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.2× (2.16%)
FY2024 2.3× 6.09%
FY2023 2.1× (2.69%)
FY2022 2.2× (4.20%)
FY2021 2.3× 15.08%
FY2020 2.0× (13.84%)
FY2019 2.3× 15.60%
FY2018 2.0× (13.79%)
FY2017 2.3× 2.71%
FY2016 2.3× 23.16%

Quarterly newest first

Period EV/Sales Change
Jun 2026 2.5× 3.82%
Mar 2026 2.4× 7.06%
Dec 2025 2.2× (9.35%)
Sep 2025 2.5× 1.22%
42 more quarters

Against its own ten years

Low 1.6× High 2.8×
Ten-year median 2.1×
Current reading's percentile 98

EV/Sales against peers

Company EV/Sales
LH Labcorp Holdings Inc. compare 2.2×
DGX Quest Diagnostics Incorporated 2.7×
MEDP Medpace Holdings, Inc. compare 6.1×
RVTY Revvity Inc. compare 6.6×
MTD Mettler-Toledo International, Inc. compare 8.4×
ILMN Illumina, Inc. compare 9.0×
IDXX IDEXX Laboratories, Inc. compare 9.8×
WAT Waters Corporation compare 10.2×
GH Guardant Health, Inc. compare 18.2×
Diagnostics & Research industry median 5.5×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on DGX